Last reviewed · How we verify
NCT05517148
Effects of an Immersive Virtual Reality Intervention Combined With Mindfulness-based Stress Reduction
NA trial testing Therapeutic VR in Stress in 80 participants. Completed in 30 January 2023.
30 January 2023
Quick facts
| Lead sponsor | Nanjing University of Traditional Chinese Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 80 |
| Start date | 25 September 2022 |
| Primary completion | 30 January 2023 |
| Estimated completion | 30 January 2023 |
| Sites | 2 locations across China |
Drugs / interventions tested
- Therapeutic VR
Conditions studied
- Stress — all drugs for Stress →
- COVID-19 Pandemic — all drugs for COVID-19 Pandemic →
- Nurse's Role — all drugs for Nurse's Role →
Sponsor
Nanjing University of Traditional Chinese Medicine
Who can join
Eligibility, any sex, with Stress or COVID-19 Pandemic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mindfulness-based stress reduction (MBSR), a widely used method to improve mental state and sleep quality, was developed by Kabat-Zinn in 1970. The meditation of MBSR is effective in regulating patients' emotions, leading to reduced stress, pain, and psychological symptoms. Studies have demonstrated that MBSR has a positive impact on multiple psychological and physical symptoms in a variety of cancers. On this basis, investigators found that VR treatment can also help patients relax, and it has been widely used in cancer symptom relief in recent years. VR treatment involves using headset devices that fully restrict the vision field to content displayed inside the headset screen; As a treatment modality, VR provides a unique environment comprising 3D visually immersive experiences that are enriched with stereo sounds and elements such as rich colors and scenic environments that enhance elicitation of desired states of arousal and affect. Within the therapeutic context, VR may be flexibly designed and tailored to address the needs of specific conditions (eg, anxiety, depression, pain) auditory perception is not fully restricted, though the corresponding device-delivered auditory content commands attention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05517148
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stress
Currently open trials in the same condition.
- NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
- NCT07469527 — Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults · NA · recruiting
- NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
- NCT07240792 — Development of a College Student-Delivered Cognitive-Behavioral Therapy (CBT) Intervention for Rural High School Student · NA · recruiting
- NCT07518056 — Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students · recruiting
Other Nanjing University of Traditional Chinese Medicine trials
Trials by the same sponsor.
- NCT06278675 — Multiple Study of Electroaccpuncture in ARDS · NA · not yet recruiting
- NCT05848934 — Research on the Relationship Between Cognitive Function Changes and Cerebrovascular Health in Patients With Coronary Hea · unknown
- NCT05848921 — Evaluation of Brain Health and Surgical Efficacy in Patients With Carotid Artery Stenosis · unknown
- NCT05613504 — Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer. · NA · not yet recruiting
- NCT05539261 — Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05517148 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nanjing University of Traditional Chinese Medicine
- Last refreshed: 23 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05517148.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing